Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new 99mTc-complex with a germanium-hydrazide (GeTH) ligand

P R Singh1, K K Katti, K V Katti

  • 1Department of Radiology, University of Missouri, Columbia, USA.

Nuclear Medicine and Biology
|November 1, 1994
PubMed
Summary

Researchers developed a novel tetrahydrazido-germanium ligand for technetium-99m (99mTc) radiolabeling. The resulting 99mTc-chelate demonstrates high stability and efficient formation under neutral conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nematodes associated with terrestrial gastropod molluscs in Belgium and additional characterisation of <i>Pellioditis californica</i> and <i>P. hermaphrodita</i>.

Journal of helminthology·2024
Same author

Survey of slug-parasitic nematodes in East and West Flanders, Belgium and description of <i>Angiostoma gandavensis</i> n. sp. (Nematoda: Angiostomidae) from arionid slugs.

Journal of helminthology·2019
Same author

Mangiferin functionalized radioactive gold nanoparticles (MGF-<sup>198</sup>AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy.

Dalton transactions (Cambridge, England : 2003)·2017
Same author

Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.

Nuclear medicine and biology·2003
Same author

Syntheses, in vitro and in vivo characterization of a 99mTc-(I)-tricarbonyl-benzylamino-dihydroxymethyl phosphine (NP(2)) chelate.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2003
Same author

Crystal structures of tris(8-dimethylaminonaphthyl)phosphane and its hydrochloride salt. The first seven-coordinate phosphorus compound.

Inorganic chemistry·2003

Area of Science:

  • Radiochemistry
  • Inorganic Chemistry
  • Nuclear Medicine

Background:

  • Development of stable radiometal chelates is crucial for diagnostic imaging.
  • Technetium-99m (99mTc) is a widely used radionuclide in nuclear medicine, requiring efficient chelation.
  • Novel ligand design can improve the stability and efficacy of 99mTc radiopharmaceuticals.

Purpose of the Study:

  • To synthesize and characterize a new tetrahydrazido-germanium (GeTH) ligand.
  • To complex the GeTH ligand with technetium-99m (99mTc).
  • To evaluate the stability and formation characteristics of the 99mTc-GeTH complex.

Main Methods:

  • Synthesis of the tetrahydrazido-germanium (GeTH) ligand.
  • Complexation reaction of GeTH with 99mTc under neutral pH conditions.

Related Experiment Videos

  • In vitro and in vivo stability assessments of the 99mTc-chelate.
  • Main Results:

    • Successful synthesis and characterization of the GeTH ligand.
    • High yield formation of the negatively charged 99mTc-GeTH chelate.
    • Demonstrated high in vitro and in vivo stability of the 99mTc-chelate without additional reducing agents.

    Conclusions:

    • The tetrahydrazido-germanium ligand is a promising chelator for 99mTc.
    • The 99mTc-GeTH complex exhibits favorable characteristics for potential radiopharmaceutical applications.
    • This new chelation method offers an efficient route to stable 99mTc radiometals.